* Results shown are group averages. Individual results may vary.
32%Faster Reaction Time
50%Fewer Attention Lapses
57%Better Distraction Control
70%Higher Focus Rating
Placebo-controlled PVT study (n=50). Results shown are group averages.
Full test records and statistical details can be provided upon request.
CRAMZY Focus Science Test (n=50)
Overview
To evaluate CRAMZY’s impact on focus and attention performance more objectively, we conducted a controlled test with
50 participants. Under standardized testing conditions, we collected both:
Objective performance: reaction time, attention lapses (PVT errors), and distraction resistance
Subjective experience: participants’ self-rated focus state during the session
The core question was simple:
Can CRAMZY help you enter focus faster in distracting environments, maintain steadier attention, and reduce “mind-wandering” moments?
Approach
1) Study design
Participants: 50 (n=50)
Comparison: CRAMZY vs placebo
Testing environment: standardized devices and workflow; tasks administered in a fixed order to reduce environmental noise
How results are shown: group averages with relative % differences (as displayed above)
2) Why these tasks?
We selected metrics commonly used in attention research that help distinguish “true focus” from short-lived stimulation:
A. PVT (Psychomotor Vigilance Task)
Measures sustained attention and vigilance, especially capturing brief “dropout” moments.
Reaction Time: lower is better (faster, steadier responses)
Errors / Lapses: fewer is better (fewer moments of freezing, delayed responses, or missed stimuli)
B. Stroop Interference RT
Measures distraction resistance / attentional control—how well you stay accurate and fast when information conflicts.
Lower Interference RT: better ability to ignore distractions and return to the task
C. Subjective Focus
Participants rated perceived focus on a 1–10 scale (closer to real-world experience).
Results
Result 1: PVT Reaction Time — 32% faster
CRAMZY: 220 ms
Placebo: 320 ms
Conclusion: 32% faster reaction time
In tasks that demand rapid response and sustained attention, the CRAMZY group performed more cleanly:
faster to lock in, quicker to respond, and less sluggish across the session.
Result 2: PVT Errors (Lapses) — 50% fewer
CRAMZY: 2 lapses
Placebo: 4 lapses
Conclusion: 50% fewer lapses
A lapse can be understood as a brief attention dropout—those half-second blank moments where responses slow dramatically or stimuli are missed.
Cutting lapses by 50% suggests more stable attention, not just a temporary buzz.
Result 3: Stroop Interference RT — 57% improvement
CRAMZY: 60 ms
Placebo: 140 ms
Conclusion: 57% better (lower is better)
The Stroop task tests control under conflict and distraction.
A 57% improvement indicates the CRAMZY group filtered noise faster, returned to the task more quickly, and kept momentum with fewer derailments.
Result 4: Subjective Focus — 70% higher rating
CRAMZY: 8.5 / 10
Placebo: 5 / 10
Conclusion: 70% higher perceived focus
This answers the most practical question: Do you actually feel focused—and can you keep going?
Moving from 5 to 8.5 typically matches lower start friction, less task-switching, and a cleaner, more controllable focus state.
Took Cramzy the first time and it felt like the fog goes away almost right away.
— Dylan, Software Engineer
Interpretation
Taken together, the four outcomes point to one consistent signal:
Faster: shorter reaction time (220ms vs 320ms)
Steadier: fewer attention dropouts (2 vs 4 lapses)
More distraction-resistant: stronger control under interference (60ms vs 140ms)
More noticeable: higher subjective focus (8.5 vs 5)
In other words, CRAMZY supports stable vigilance + stronger attention control + a more sustainable focus experience—
rather than a short-lived spike.
Notes
Results shown are group averages under standardized test conditions and reported as relative differences.
Individual experiences may vary based on sleep, caffeine habits, stress, diet, and day-to-day baseline.
CRAMZY is a dietary supplement intended to support focus and cognitive performance. It is not intended to diagnose, treat, cure, or prevent any disease.
† These statements have not been evaluated by the Food and Drug Administration.